MyFinsight
Home
Blog
About
Contact
Download
Download image
Exercise of warrants
$2,919,812
Proceeds from public
offering net (common...
$1,828,596
Net cash flows
provided by financing...
$4,748,408
Net (decrease) in
cash and cash...
-$1,418,971
Canceled cashflow
$4,748,408
Intangible assets
impairment
$1,748,247
Prepaid expenses
-$480,798
Depreciation and
amortization
$332,070
Right-of-use asset
-$203,836
Disposal of tangible
assets
$10,257
Net cash flows (used
in) operating...
-$5,331,073
Canceled cashflow
$2,775,208
Net cash flows (used
in) investing...
-$836,306
Net (loss)
-$5,975,352
Inventory
$1,637,277
Accounts payable &
accrued expenses
-$189,956
Lease liability
-$187,523
Accounts receivable
$116,173
Purchase of intangible
assets
$661,815
Purchase of equipment
$174,491
Back
Back
Cash Flow
source: myfinsight.com
Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma Inc. (SBFMW)